股票代码：******

Polish the golden brand of the health industry to add brilliance and color to the 14th Five-Year Plan

Published:

2021-02-08

On the morning of September 15, 2020, at 11:30 AM, Zhang Zhiqiang, Director of the Chengdu Documentation Center of the Chinese Academy of Sciences, Zhang Hui, Deputy Director of the Health Development Research Center of the National Health Commission, and a team of 6 members, accompanied by Chen Xiaohua, Deputy Director of the Ji'an Municipal Bureau of Industry and Information Technology, visited our company to comprehensively understand the foundation of the health industry, the development situation during the 13th Five-Year Plan period, and its influence within the industry. They focused on specific difficulties and problems encountered in the advancement of key enterprises and projects, and solicited opinions and suggestions for the industrial development ideas and planning for the 14th Five-Year Plan period. After visiting the workshop, the research team held a discussion with the company's senior executives at home. General Manager Yao Xiaodong first introduced the company's production and operation status and development strategic planning to the research team.

Yao Xiaodong stated that the development of the enterprise cannot be separated from the long-term reasonable planning of the local government. Today's visit to our company for the 14th Five-Year Plan research on the health industry also reflects the local government's care and attention to us. In recent years, under the care and support of the local government, Jiangxi Bio has developed rapidly and made great progress. We are also very optimistic about development in the antitoxin field and are willing to fully leverage the role of the enterprise in the real economy and in safeguarding people's health. After entering the Jingkai District, the company has focused on accelerating high-quality leapfrog development, insisting on making existing products solid, strong, and excellent as the main direction, comprehensively strengthening innovation capabilities, improving the modernization level of the industrial chain, firmly implementing the serum product development strategy, steadily advancing around the construction of a new development pattern, deeply implementing the bio-pharmaceutical industry-driven agricultural and animal husbandry development campaign, solidly improving and upgrading key product quality, striving to enhance new development momentum and advantages, continuously activating the endogenous power of bio-pharmaceutical revitalization, and striving to create a higher-level beautiful China "Jiangxi Model." We will take this as a new starting point, fully leverage our platform advantages, actively increase support in major basic research and development, the health industry, and agricultural and animal husbandry development, and strengthen cooperation with cutting-edge research institutes at deeper levels and higher standards to achieve mutual benefit and common development.
The research team believes that Jiangxi Bio has a solid foundation, with abundant main raw material guarantees and a complete range of biological product industry systems, a good green ecological environment, and splendid agricultural and animal husbandry culture. Its comprehensive benefits and competitiveness are continuously improving, and it is currently accelerating its transition from a large antitoxin enterprise to a strong blood product enterprise. At the same time, the research team believes that in the 14th Five-Year Plan, we must deeply recognize the huge development potential of biomedicine, the broad market space, and patients' higher expectations for product quality. We should view and grasp the company's development opportunities and challenges with a comprehensive, dialectical, and long-term perspective. In formulating the Ji'an health industry 14th Five-Year Plan, we must strengthen the crisis awareness of "no progress means regression," the opportunity awareness of adapting to changes, and the enterprising spirit of innovation. We should paint a more brilliant and colorful blueprint for making the health industry the city's second largest trillion-yuan industry after the electronic information industry. In future development, the company must continuously explore and expand the huge potential, broad space, and bright prospects of biological product development, writing a more exciting new chapter of modernization.

The Jiangxi Provincial Bureau of Statistics visited our company to conduct a data verification for the annual R&D statistics report.

Municipal Party Secretary Hu Shizhong visits and extends condolences to disadvantaged party members along with six team members

Add:

Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China

Board Office:

Domestic Sales:

International Sales: